Osprey Private Wealth LLC Acquires 125 Shares of Danaher Co. (NYSE:DHR)

Osprey Private Wealth LLC increased its holdings in shares of Danaher Co. (NYSE:DHR) by 1.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 11,250 shares of the conglomerate’s stock after acquiring an additional 125 shares during the period. Danaher comprises 1.8% of Osprey Private Wealth LLC’s portfolio, making the stock its 24th biggest position. Osprey Private Wealth LLC’s holdings in Danaher were worth $2,582,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of DHR. Stratos Investment Management LLC increased its holdings in Danaher by 19.7% during the 4th quarter. Stratos Investment Management LLC now owns 1,618 shares of the conglomerate’s stock worth $371,000 after purchasing an additional 266 shares during the period. Sargent Investment Group LLC increased its holdings in Danaher by 10.5% during the 4th quarter. Sargent Investment Group LLC now owns 13,958 shares of the conglomerate’s stock worth $3,348,000 after purchasing an additional 1,322 shares during the period. Ninety One UK Ltd increased its holdings in Danaher by 3.4% during the 4th quarter. Ninety One UK Ltd now owns 134,189 shares of the conglomerate’s stock worth $30,803,000 after purchasing an additional 4,434 shares during the period. E. Ohman J or Asset Management AB increased its holdings in Danaher by 8.6% during the 4th quarter. E. Ohman J or Asset Management AB now owns 29,260 shares of the conglomerate’s stock worth $6,717,000 after purchasing an additional 2,310 shares during the period. Finally, Mather Group LLC. increased its holdings in Danaher by 6.8% during the 4th quarter. Mather Group LLC. now owns 9,540 shares of the conglomerate’s stock worth $2,190,000 after purchasing an additional 609 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

Shares of DHR opened at $215.05 on Wednesday. The stock has a 50-day moving average of $234.93 and a two-hundred day moving average of $252.88. Danaher Co. has a one year low of $210.04 and a one year high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock has a market cap of $155.33 billion, a P/E ratio of 40.73, a P/E/G ratio of 2.80 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the firm posted $2.09 earnings per share. As a group, research analysts predict that Danaher Co. will post 7.77 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were paid a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.50%. Danaher’s dividend payout ratio is presently 20.45%.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 10.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on DHR shares. Citigroup cut their price target on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 30th. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a report on Friday, December 13th. Jefferies Financial Group cut their price target on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. JPMorgan Chase & Co. cut their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Raymond James reiterated a “market perform” rating on shares of Danaher in a report on Monday. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.